Chugai Pharmaceutical Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly and | Outperform |
16
|
$807.43 | Buy/Sell | $636.99 | 8.68% | 9 | $727.01B |
| JNJ | Johnson & Johnson | Outperform |
9
|
$146.97 | Buy/Sell | $174.55 | 15.67% | 3 | $353.71B |
| ABBV | AbbVie | Outperform |
9
|
$157.06 | Buy/Sell | $178.42 | 16.20% | 11 | $277.35B |
| AZN | AstraZeneca PLC | Outperform |
17
|
£122.96 | Buy/Sell | £165.99 | 37.18% | 16 | £190.62B |
| ROG | Roche Holding | Hold |
16
|
CHF229.90 | Buy/Sell | CHF307.83 | 18.53% | 9 | CHF185.94B |
| PFE | Pfizer | Outperform |
2
|
$28.88 | Buy/Sell | $32.87 | 5.51% | 6 | $163.65B |
| SAN | Sanofi | Outperform |
16
|
89.86€ | Buy/Sell | 102.80€ | 21.30% | 9 | 112.34€B |
| REGN | Regeneron Pharmaceuticals | Outperform |
2
|
$985.02 | Buy/Sell | $961.26 | 6.60% | 8 | $106.27B |
| GSK | GSK | Outperform |
12
|
£17.75 | Buy/Sell | £17.30 | 12.39% | 12 | £72.36B |
| BMY | Bristol-Myers Squibb | Hold |
2
|
$41.24 | Buy/Sell | $58.15 | 30.94% | 10 | $83.60B |